Concepedia

Author

Dirk Bauerschlag

University Hospital Schleswig-HolsteinORCID

Also Known As

Bahriye Aktas, Bauerschlag, Bauerschlag Dirk, Benoît You, D Bauerschlag, D O Bauerschlag, D. Bauerschlag, D. O. Bauerschlag, D.O. Bauerschlag, DIRK BAUERSCHLAG

277

Publications

3.7K

Citations

29

H-Index

94

Concepts

All Affiliations

University Hospital Schleswig-HolsteinUniversity of LübeckChristian-Albrechts-Universität zu KielRWTH Aachen UniversityUniversitätsklinikum Aachen
DB

About

Dirk Bauerschlag is an author at University Hospital Schleswig-Holstein specializing in medicine, obstetrics, and ovarian cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

24

898

2

Health Sciences

5

5

281

3

Engineering

1

1

39

4

Natural Sciences

1

1

12

5

Biochemistry

1

1

12

Dirk Bauerschlag

×

55

Publications

2.9K

Citations

27

H-Index

YearCitations

Aging of blood can be tracked by DNA methylation changes at just three CpG sites

Carola I. Weidner, Qiong Lin, Carmen Koch,

Genome biology

2014

926

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

Ivo Meinhold‐Heerlein, Dirk Bauerschlag, Felix Hilpert,

Oncogene

2004

205

Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer

Dirk Bauerschlag, Nicolaì Maass, P Leonhardt,

Journal of Translational Medicine

2015

130

One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group

Christian Schem, Nicolaì Maass, Dirk Bauerschlag,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2008

110

Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells

Hans‐Heinrich Oberg, Christian Kellner, Daniel Gonnermann,

Frontiers in Immunology

2018

97

Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy

Paul Lennart Vollmers, Christoph Mundhenke, Nicolaì Maass,

Journal of Cancer Research and Clinical Oncology

2018

96

Maternal and fetal cord blood lipids in intrauterine growth restriction

Ulrich Pecks, Meike Brieger, Dirk Bauerschlag,

Journal of Perinatal Medicine

2012

86

A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

Klaus Baumann, Andreas du Bois, Werner Meier,

Annals of Oncology

2012

84

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

Marion T. Weigel, Linda Dahmke, Christian Schem,

BMC Cancer

2010

56

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Ivo Meinhold‐Heerlein, Dirk Bauerschlag, Yingyao Zhou,

Clinical Cancer Research

2007

53

Page 1